Andrea Goren - Jan 15, 2022 Form 4 Insider Report for INVO Bioscience, Inc. (INVO)

Role
Chief Financial Officer
Signature
/s/ Andrea Goren
Stock symbol
INVO
Transactions as of
Jan 15, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 08:26 PM
Previous filing
Oct 7, 2021
Next filing
Jun 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Award $0 +5.36K +42.89% $0.00 17.9K Jan 15, 2022 Direct
holding INVO Common Stock 5K Jan 15, 2022 Direct F1
holding INVO Common Stock 76.4K Jan 15, 2022 Via Andax LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option Award $0 +15.2K $0.00 15.2K Jan 15, 2022 Common Stock 15.2K $3.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units which vest in substantially equal monthly increments over a period of 12 months from the date of grant of July 1, 2021
F2 The stock option vests in monthly increments over a period of three years from the date of grant.